Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Clinical approaches to hypersomnolence complaints in psychiatry: A narrative review
Pierre A Geoffroy1, Nausicaa Christodoulou2, Jean-Arthur Micoulaud Franchi3
1Département de psychiatrie et d'addictologie, Hôpital Bichat-Claude-Bernard, AP-HP, GHU Paris Nord, DMU Neurosciences, 75018 Paris, France; Psychiatry & Neurosciences, GHU Paris, 1, rue Cabanis, 75014 Paris, France; Inserm U1141, Université de Paris, NeuroDiderot, 75019 Paris, France; CNRS UPR 3212, Institute for Cellular and Integrative Neurosciences, 5, rue Blaise-Pascal, 67000 Strasbourg, France.
Background:
Hypersomnolence complaints are common in psychiatric disorders and carry substantial functional burden, yet they remain under-recognized and frequently under-investigated. Clinically, hypersomnolence spans three partially overlapping dimensions: excessive daytime sleepiness, excessive total sleep time/need for sleep, and sleep (wake) inertia.
Objective:
To provide a pragmatic, clinician-oriented framework for evaluating and managing hypersomnolence complaints in psychiatry, integrating sleep medicine concepts with psychiatric comorbidity and real-world care pathways.
Methods:
Narrative synthesis of epidemiological, clinical, and translational evidence with emphasis on: (i) precise phenotypic clarification of the complaint; (ii) systematic etiological work-up (sleep debt and circadian misalignment, depressive episodes, ADHD, anxiety/trauma-related disorders, iatrogenic factors, OSA, RLS, parasomnias, narcolepsy/idiopathic hypersomnia); and (iii) stepwise management strategies.
Results:
Hypersomnolence affects 40-50% of patients in major depressive episodes and is frequently linked to circadian factors, insomnia comorbidity, obstructive sleep apnea, and medication effects. Objective long sleep time is common among depressed patients with hypersomnolence. Similar observations are made for ADHD, anxiety and trauma-related disorders and psychotics disorders. A three-step care algorithm is proposed: (1) universal behavioral/circadian measures; (2) targeted treatment of the underlying cause (e.g., antidepressant optimization, chronotherapeutics, CBT-I, CPAP/MAD for OSA, specific management for RLS/parasomnias, and specialist evaluation for narcolepsy/idiopathic hypersomnia); (3) management of residual symptoms (e.g., light therapy; carefully selected wake-promoting agents when indicated).
Conclusions:
A fine-grained clinical characterization coupled with systematic etiological screening improves diagnosis and treatment of hypersomnolence in psychiatry. Integrating sleep-specific tools (actigraphy, sleep diaries, MSLT/PSG when appropriate) with psychiatric assessment supports personalized, mechanism-informed care and may reduce morbidity, accident risk, and healthcare utilization.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia
Multiple factors contribute...
Narcolepsy
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

